Last reviewed · How we verify
NCT07054710
Evaluation of the Efficacy of a Cosmetic Light Mask
NA trial testing LED Light Treatment in Fine Lines in 115 participants. Completed in 1 September 2025.
1 September 2025
Quick facts
| Lead sponsor | Therabody, Inc. |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 115 |
| Start date | 5 May 2025 |
| Primary completion | 1 September 2025 |
| Estimated completion | 1 September 2025 |
| Sites | 1 location across United States |
Drugs / interventions tested
- LED Light Treatment
- Vibration Only
Conditions studied
- Fine Lines — all drugs for Fine Lines →
- Contour — all drugs for Contour →
- Sagging Skin — all drugs for Sagging Skin →
- Dark Spots — all drugs for Dark Spots →
Sponsor
Therabody, Inc.
Who can join
Adults 35 to 65, any sex, with Fine Lines or Contour. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The present study evaluated facial skin health over a 12-week period using an at-home device that provides 12 minutes of LED light and vibration once daily, six days a week. The primary question it seeks to answer is whether daily use of the TheraFace Mask Glo alters facial skin characteristics. Secondary aims include collecting clinical images, professional photographs, and consumer perceptions of the device. Participants between the ages of 39-64 with various skin types were enrolled for participation. Participants visited the clinic three times for collection of outcome metrics at baseline, 8 weeks, and 12 weeks. Participants also came to the lab at 4 weeks for a compliance check. Measurements included: expert clinical grading, digital imaging, subjective assessment of skin, and clinical grade-images.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT07054710
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other recruiting trials for Fine Lines
Currently open trials in the same condition.
- NCT07111156 — A Clinical Study to Test the Safety and Effectiveness of Pinorox® for Improving Visible Signs of Facial Aging Such as Wr · NA · active not recruiting
- NCT06869252 — Autologous Adipose Cells Therapy · Phase 1, PHASE2 · recruiting
- NCT04540900 — A Phase I Study of KB301, a Replication-Incompetent, Non-Integrating Vector Expressing Human Type III Collagen (COL3) fo · Phase 1 · active not recruiting
Other Therabody, Inc. trials
Trials by the same sponsor.
- NCT07510581 — Evaluatation of a Microcurrent + Cold Therapy Device · NA · enrolling by invitation
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT07054710 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Therabody, Inc.
- Last refreshed: 9 September 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT07054710.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing